USPTO serial 77772014
PFLUEGER
Reviewed by CopyMark Law Group
Reg. 3836739Status 710
- Filing date
- Status date
- Registration date
- Aug 24, 2010
- Examiner
- RITTNER, HANNO I
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with PFLUEGER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
HOMÖOPATHISCHES LABORATORIUM ALEXANDER PFLÜGER GmbH & CO., KG
Rheda-Wiedenbrück, DE
Other trademarks owned by HOMÖOPATHISCHES LABORATORIUM ALEXANDER PFLÜGER GmbH & CO., KG
HOMÖOPATHISCHES LABORATORIUM ALEXANDER PFLÜGER GmbH & CO., KG
Rheda-Wiedenbrück, DE
Other trademarks owned by HOMÖOPATHISCHES LABORATORIUM ALEXANDER PFLÜGER GmbH & CO., KG
HOMÖOPATHISCHES LABORATORIUM ALEXANDER PFLÜGER GmbH & CO., KG
Rheda-Wiedenbrück, DE
Other trademarks owned by HOMÖOPATHISCHES LABORATORIUM ALEXANDER PFLÜGER GmbH & CO., KG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard S. Roberts
RICHARD S. ROBERTS ROBERTS & ROBERTS, LLP, ATTORNEYS AT LAWPO BOX 484PRINCETON, NJ 08542-0484UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Homeopathic medicines, pharmaceutical preparations, organic healthcare preparations and nutritional additives for use in the treatment of abscess, achylia gastrica, acidosis, acne vulgaris, adiposity, adnexitis, adynamia, agranulocytosis, albuminuria, allergies, alopecia, amenorrhoea, amyotrophy, anal fissure, anal pruritus, angina pectoris, angiopathia, anosmia, anuria, aphasia, apoplexy, appendicitis, arteriosclerosis, arthritis, arthrosis, ascites, asthenopia, back pain, bechterew's disease, blackheads, blepharitis, bronchial asthma, bronchiectasis, bronchitis, bruise, bursitis, cancer, cardiac asthma, cardiac insufficienca, chillblains, cholangitis, cholecystitis, cholelithiasis choroiditis, circulatory disorders, cirrhosis of the liver, colds, colics, colitis, concussion, conjunctivitis, constipation, contusion, cough and sneezing, cyctitis, decubitus ulcer, dementia, depression, dermatitis, diabetes mellitus, diarrhea, distorsion diverticulitis, duodenitis, dysmenorrhea, dyspepsia, dyspnea, dystonia, dysuria, eczema, eczema of the auditory channel, endometritis, enuresis, epicondylitis, lateral humeral, erythema, exanthema, exhaustion, extrasystoles, fainting, fatty liver, fever, fibrosis of the liver, flatulence, frostbite, frozen shoulder, gastralgia, gastritis, glomerulonephritis, gout, gravidity, hardening of the mammary gland, hayfever, headache, heartburn, hemorrhoids, hepatitis, hernia of diaphragma, inguinal hernia, incisinal hernia, herpes labialis, hordeolum, hyperacidity, hypercholesterolaemia, hyperemia, hyperhidrosis, hypermenorrhea, hypertension, hysteria, icterus, impaired hearing, impotency, infantile eczema, inflammation, inflammation of the rectum, insomnia, iritis, keratitis, laryngitis, lichens, low immunity, lumbago, luxation, lymphadenitis, mastitis, measles, meniere's disease, menorrhagia, migraine, myalgia, myopia, nausea, nephrolithiasis, nervousness, neuralgia, neurasthenia, neuritis, neurodermitis, osteoporosis, otitis externa, otitis media, ozaena, pancreatitis, paraesthesia of extremities, pemphigus, periostitis, pharyngitis, phlebitis, pneumonia, nasal polyps, prolapsus ani, prostatitis, pruritus, psoriasis, pyelitis, spasms of pylorus, retinitis, rheumatism, rhinitis, roemheld's syndrome, sciatic pain, seborrhea, shingles, sinusitis, spasms, cramps, splenitis, stomach cramps, sycosis barbae, tinnitus, tonsillitis, tracheitis, travel sickness, trigeminal neuralgia, ulcus cruris, ulcus duodeni, ulcus ventriculi, umbilical colics of children, ureteritis, urticaria, vaginitis, varicosis, venous congestions, vertigo, vomitus, warts, weakness of connective tissue, weakness of memory; dietary supplements for medicinal purposes, and food supplements | SECTION 8 - CANCELLED | Jul 1, 2004 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HOMÖOPATHISCHES LABORATORIUM ALEXANDER PFLÜGER GmbH & CO., KG
- Other trademarks owned by HOMÖOPATHISCHES LABORATORIUM ALEXANDER PFLÜGER GmbH & CO., KG
- Other trademarks owned by HOMÖOPATHISCHES LABORATORIUM ALEXANDER PFLÜGER GmbH & CO., KG
- Other trademarks in Class 005
- Similar marks named PFLUEGER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 7, 2017 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 24, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 8, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 8, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 1, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 30, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 30, 2010 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 30, 2010 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 30, 2010 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 30, 2010 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 29, 2010 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Apr 23, 2010 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Apr 9, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 9, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 7, 2010 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 7, 2010 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 7, 2010 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 7, 2010 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 1, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 1, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 1, 2010 | ALIE | ASSIGNED TO LIE | — |
| Mar 24, 2010 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Mar 24, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 7, 2009 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Jul 6, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 4, 2009 | NWAP | NEW APPLICATION ENTERED | — |